# A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease

> **NCT01632462** · PHASE4 · UNKNOWN · sponsor: **Federico II University** · enrollment: 30 (estimated)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** VSL#3

## Key facts

- **NCT ID:** NCT01632462
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2014-12
- **Final completion:** 2015-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01632462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01632462, "A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01632462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*